<div id="hybrid-search-3" class="widget search widget-search"><div class="widget-inside"><form method="get" class="search-form" id="search-form" action="https://rare-diseases.ca/"><div><input class="search-text" type="text" name="s" id="search-text" value="" onfocus="if(this.value==this.defaultValue)this.value='';" onblur="if(this.value=='')this.value=this.defaultValue;" /><input class="search-submit button" name="submit" type="submit" id="search-submit" value="Search" /></div></form><!-- .search-form --></div></div>
Rare Diseases
<div id="hybrid-nav-menu-3" class="widget nav-menu widget-nav-menu"><div class="widget-inside"></div></div>
<div class="breadcrumb breadcrumbs"><div class="breadcrumb-trail"> » <a href="https://rare-diseases.ca" title="" rel="home" class="trail-begin">Home</a> <span class="sep">»</span> <a href="https://rare-diseases.ca/topics/news-updates/" rel="tag">News & Media</a> <span class="sep">»</span> Genome sequencing: A costly way to save </div></div>

Genome sequencing: A costly way to save


The promise of genome sequencing is letting doctors pick the right cancer drug the first time. But the ability to target specific cancer types is giving rise to new and expensive specialty drugs.

Click here to read the full article from the May 4, 2014 edition of The Vancouver Sun.